EMEA-002233-PIP01-17-M02 - paediatric investigation plan

Dasiglucagon
PIPHuman

Key facts

Active Substance
Dasiglucagon
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0176/2023
PIP number
EMEA-002233-PIP01-17-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hypoglycaemia
Route(s) of administration
Subcutaneous use
Contact for public enquiries

Zealand Pharma A/S

E-mail: info@zealandpharma.com
Tel: + 45 50603821

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page